Technical Description
The invention encapsulates hydrophilic actives inside solid microgranules for controlled, rapid-release drug delivery. Operating at room temperature via emulsion crosslinking, this zero-solvent method avoids harsh chemicals and protects sensitive compounds from thermal degradation. By overcoming the trapping flaws of traditional polymer-only carriers, the matrix acts as a versatile vehicle optimized to release active agents under simulated biological intestinal conditions.
Problems Addressed
- High Temperature Operational Processes
- Degradation of Heat-Sensitive Active Agents
- Reduced Shelf life and Material Effectiveness
- Dependency on Complex and High-Cost Equipment
Tech Features
- Room-Temperature Processing
- Emulsion-Crosslink Integration
- Embedded Silica Escape Vectors
- Tunable Micro-Scale Sizing(15 µm - 60 µm)
- High-Efficiency Solid Recovery
- Optimized Active Agent Delivery
Target Audience
- Pharmaceutical & Drug Delivery Sectors
- Agricultural & Pest Control Manufacturers
- Functional Food, Nutraceutical, & Cosmetic Processors
Tech ID: P21-2127 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
